Article

June 2008 Sworn Statement

June 2008 Sworn Statement

External Link - article-579027.pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Michael Grosberg
Related Content
Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration
August 26th 2025

Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 26th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 26th 2025

Genentech Breaks Ground for New Manufacturing Facility in North Carolina

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 26th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events
August 26th 2025

FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events

Don Tracy, Associate Editor
AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder
August 26th 2025

AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder

Don Tracy, Associate Editor